Generated: December 18, 2017
DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 208147
« Back to Dashboard
describes DYANAVEL XR
, which is a drug marketed by Tris Pharma Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the DYANAVEL XR profile page.
The generic ingredient in DYANAVEL XR is amphetamine. There are fifty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amphetamine profile page.
Summary for 208147
|Formulation / Manufacturing:||see details|
Pharmacology for NDA: 208147
Medical Subject Heading (MeSH) Categories for 208147
Suppliers and Packaging for NDA: 208147
||National Drug Code
||SUSPENSION, EXTENDED RELEASE;ORAL
||Tris Pharma Inc
||464 mL in 1 BOTTLE (27808-102-01)
|Complete Access Available with Subscription
Summary for product number 001
|Active Rx/OTC/Discontinued:||RX||Dosage:||SUSPENSION, EXTENDED RELEASE;ORAL||Strength||EQ 2.5MG BASE/ML|
|Approval Date:||Oct 19, 2015||TE:||RLD:||Yes|
|Regulatory Exclusivity Expiration:||Oct 19, 2018
|Regulatory Exclusivity Use:||NEW PRODUCT|
|Patent:||► Subscribe||Patent Expiration:||Mar 29, 2029||Product Flag?||Y||Substance Flag?||Delist Request?|
|Patent:||► Subscribe||Patent Expiration:||Mar 15, 2027||Product Flag?||Y||Substance Flag?||Delist Request?|
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.